載入...
A phase II study of the safety of olanzapine for oxaliplatin based chemotherapy in coloraectal patients
Olanzapine has exhibited efficacy as an antiemetic agent when used with 5-HT(3) receptor antagonists, dexamethasone, and NK(1) receptor antagonists for patients receiving highly emetogenic chemotherapy. In addition, several studies have reported the efficacy or safety of olanzapine in patients recei...
Na minha lista:
發表在: | Sci Rep |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Nature Publishing Group UK
2021
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7907185/ https://ncbi.nlm.nih.gov/pubmed/33633328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-84225-6 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|